605 studies found for:    HAART
Show Display Options
Rank Status Study
21 Completed Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients
Condition: HIV Infection
Intervention: Drug: Maraviroc
22 Completed
Has Results
Heart Function in HIV-Negative Children Exposed to HIV and HAART
Condition: HIV Infections
Intervention:
23 Completed Effect of DHA on Lipid and Carbohydrate Metabolism Alterations and Body Fat Distribution in HIV Patients Under HAART.
Conditions: HIV-associated Hypertriglyceridemia;   HIV-associated Hypercholesterolemia;   HIV-associated Inflammatory State
Intervention: Drug: Docosahexaenoic acid (DHA) administration to modulate Triglycerides in HIV patients under HAART
24 Unknown  Effects of a Phone Call Intervention to Promote HAART Adherence
Condition: Medication Adherence
Intervention: Behavioral: Phone call intervention, no phone call intervention
25 Terminated
Has Results
A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV
Conditions: Human Immunodeficiency Virus (HIV);   HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Raltegravir
26 Completed HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence
Conditions: Acute HIV Infection;   Acquired Immunodeficiency Syndrome;   Medication Adherence
Intervention: Behavioral: Advanced Adherence Counseling (AdvAdh)
27 Completed Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting
Conditions: Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting;   HIV Infections
Interventions: Drug: Dronabinol;   Drug: Placebo
28 Recruiting Antiretroviral Therapy for Acute HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: HAART;   Drug: Mega-HAART
29 Active, not recruiting New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients
Condition: HIV Infections
Interventions: Other: PHI-patients;   Other: CHI-patients
30 Withdrawn Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART
Conditions: HIV Infections;   Hyperlipidemia;   Exercise
Intervention: Dietary Supplement: l-carnitine
31 Completed An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
Conditions: HIV Infection;   Pregnancy
Intervention: Other: Tokafatso programmatic intervention
32 Completed Phase I/II, Open-Label Trial of Three Monoclonal Antibodies
Condition: HIV Infections
Intervention: Drug: Potent HAART during acute or early HIV-1 infection
33 Completed Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa
Condition: HIV
Intervention: Drug: Lopinavir/Ritonavir (200/50 mg) Tablets + Zidovudine + 3TC
34 Completed Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAART
Condition: HIV
Intervention:
35 Completed
Has Results
Effects of Intensive cART During Acute/Early HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: raltegravir;   Drug: maraviroc;   Drug: emtricitabine 200mg /tenofovir 300mg;   Drug: lopinavir 400 mg/ritonavir 100mg
36 Completed HIV Treatment and CVD Events
Conditions: HIV Infection;   Cardiovascular Disease;   Infection, Human Immunodeficiency Virus;   Acute Myocardial Infarction
Intervention: Drug: HAART Treatment
37 Completed Beta-2 Microglobulin and Serum Cytokines x HAART
Condition: HIV Patients
Intervention:
38 Terminated
Has Results
Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya
Condition: HIV Infections
Intervention: Drug: HAART
39 Unknown  Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis
Conditions: Acquired Immunodeficiency Syndrome;   Tuberculosis
Intervention: Other: Comparison of different treatment strategies
40 Completed An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART
Condition: Human Immunodeficiency Virus; HIV
Interventions: Drug: Darunavir/Ritonavir (DRV/r);   Drug: Efavirenz (EFV)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.